These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8213768)

  • 1. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.
    Matsuda J; Gohchi K; Tsukamoto M; Saitoh N; Asami K; Hashimoto M
    Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
    Galli M; Ruggeri L; Barbui T
    Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity.
    Pengo V; Brocco T; Biasiolo A; Rampazzo P; Carraro P; Zamarchi R
    Blood; 1999 Dec; 94(11):3814-9. PubMed ID: 10572096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some recent developments with lupus anticoagulants.
    Exner T
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):281-9. PubMed ID: 8054462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
    Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
    Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants.
    Pengo V; Biasiolo A; Pegoraro C; Iliceto S
    J Thromb Haemost; 2004 May; 2(5):702-7. PubMed ID: 15099274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.
    Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G
    Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four laboratory tests for lupus anticoagulant.
    Stark RA; Gordon S
    Pathology; 1990 Apr; 22(2):122-3. PubMed ID: 2122400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA; Krilis SA
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to beta 2-glycoprotein I inhibit phospholipid dependent coagulation reactions.
    Brandt JT
    Thromb Haemost; 1993 Oct; 70(4):598-602. PubMed ID: 8115986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.